ROCTAVIAN

Serial Number 97414432
Registration 7328716
700

Registration Progress

Application Filed
May 17, 2022
Under Examination
Nov 21, 2023
Approved for Publication
Sep 26, 2023
Published for Opposition
Sep 26, 2023
Registered
Mar 12, 2024

Trademark Image

ROCTAVIAN

Basic Information

Serial Number
97414432
Registration Number
7328716
Filing Date
May 17, 2022
Registration Date
March 12, 2024
Published for Opposition
September 26, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 12, 2024
Registration
Registered
Classes
005

Rights Holder

Biomarin Pharmaceutical Inc.

03
Address
105 Digital Drive
Novato, CA 94949

Ownership History

Biomarin Pharmaceutical Inc.

Original Applicant
03
Novato, CA

Biomarin Pharmaceutical Inc.

Owner at Publication
03
Novato, CA

Biomarin Pharmaceutical Inc.

Original Registrant
03
Novato, CA

Legal Representation

Attorney
Richard M. LaBarge

USPTO Deadlines

Next Deadline
1542 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240312)
Due Date
March 12, 2030
Grace Period Ends
September 12, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Mar 12, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 12, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 6, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Feb 5, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 30, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jan 9, 2024 IUAF S USE AMENDMENT FILED Loading...
Jan 29, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 9, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 21, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 26, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 26, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 6, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 24, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 23, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 22, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 22, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 2, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
May 2, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Mar 7, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 7, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 7, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 6, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 24, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 20, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of genetic diseases and disorders
First Use Anywhere: Dec 27, 2023
First Use in Commerce: Dec 27, 2023

Classification

International Classes
005